Next 10 |
home / stock / gmed / gmed articles
Catalent, Inc. (NYSE: CTLT) announced that it has completed the expansion of its clinical supply facility in Schorndorf, Germany. The Schorndorf si...
AUDUBON, Pa., July 16, 2024 (GLOBE NEWSWIRE) -- Globus Medical, Inc. (NYSE:GMED), a leading musculoskeletal solutions company, will announce its...
Chemed Corporation (NYSE: CHE) is primed to grow in the upcoming quarters, backed by the promising prospects of the VITAS business. The compan...
Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgr...
Globus Medical, Inc. (NYSE:GMED) shares are trading higher Wednesday after the company posted better-than-expected first-quarter financial results ...
Shares of Upstart Holdings, Inc. (NASDAQ:UPST) fell sharply during Wednesday's session after the company reported first-quarter financial resu...
U.S. stocks were mixed, with the Dow Jones gaining around 70 points on Wednesday. Shares of Louisiana-Pacific Corporation (NYSE:LPX) rose sharply d...
Globus Medical (NYSE: GMED) continues to gain from surging demand for its Musculoskeletal Solutions products. Meanwhile, the company is expanding i...
AUDUBON, Pa., Feb. 13, 2024 (GLOBE NEWSWIRE) -- Globus Medical, Inc. (NYSE:GMED), a leading musculoskeletal solutions company, will announce its...
News, Short Squeeze, Breakout and More Instantly...
Globus Medical Inc. Class A Company Name:
GMED Stock Symbol:
NYSE Market:
Globus Medical Inc. Class A Website:
AUDUBON, Pa., July 17, 2024 (GLOBE NEWSWIRE) -- Globus Medical, Inc. (NYSE: GMED), a leading musculoskeletal solutions company, today announced it recently received 510(k) clearance by the U.S. Food and Drug Administration (FDA) for ExcelsiusFlex™ with Total Knee Arthroplasty (TKA) applica...
2024-05-20 06:00:04 ET Matt O'Brien from Piper Sandler issued a price target of $80.00 for GMED on 2024-05-20 04:50:00. The adjusted price target was set to $80.00. At the time of the announcement, GMED was trading at $64.4. The overall price target consensus is at $78.6...
2024-05-11 10:32:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...